Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,291 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Active, Not Recruiting

Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

NCT05059522

Conditions
Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +17 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • The Regents of the University of California Los Angeles, California, United States
View all 71 locations
View Trial Details
Active, Not Recruiting

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

NCT04503278

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +35 more
Locations
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
  • Charité - Universitätsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany
  • Universitätsklinikum Köln AÖR-Centrum für Integrierte Onkologie (CIO)-Studienzentrum der Klinik I für Innere Medizin (CTU Cologne) Cologne, Germany
  • Universitätsklinikum Erlangen - Hämatologie & Intrinsische Onkologie - Medizinische Klinik 5 Erlangen, Germany
View Trial Details
Active, Not Recruiting

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +55 more
Locations
  • Hoag Memorial Presbyterian Newport Beach, California, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Titan Health Partners Llc Dba Astera Cancer Care East Brunswick, New Jersey, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

NCT05554367

Conditions
Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, +21 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • UC San Diego Health System - Encinitas Encinitas, California, United States
View all 266 locations
View Trial Details
Active, Not Recruiting

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

NCT01366144

Conditions
Adnexal Diseases, Breast Carcinoma, Breast Diseases, +70 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT02595892

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC San Diego Medical Center - Hillcrest San Diego, California, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors

NCT06390995

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Shikoku Cancer Center Matsuyama, Ehime, Japan
View all 20 locations
View Trial Details
Active, Not Recruiting

Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer

NCT03348631

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 582 locations
View Trial Details

Related conditions